Elevation Pharmaceuticals, Inc. Report issue

For profit Phase 1 Phase 2
Founded: San Diego CA United States (2007)
Status: Acquired by Sunovion (2012) → now Sumitomo Dainippon (2009)

Organization Overview

First Clinical Trial
2011
NCT01426009
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Chief Medical Officer / Elevation Pharmaceuticals, Inc. | Elevation Oncology | Elevation Oncology, Inc.